Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Circulating Tumor Cells in Patients With Breast Cancer Who Completed Surgery After Neoadjuvant Treatment: a Multicenter, Prospective Clinical Trial

NCT05360290 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT05360290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05360290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Circulating Tumor Cells in Patients With Breast Cancer Who Completed Surgery After Neoadjuvant Treatment: a Multicenter, Prospective Clinical Trial
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 14, 2022
Completion date
June 30, 2029
Enrollment
484 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, circulating tumor cell